Terns Pharmaceuticals, Inc.
TERN
$2.92
-$0.13-4.26%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 358.16M | 372.78M | 225.30M | 240.65M | 263.44M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.95M | 3.73M | 4.94M | 5.24M | 3.99M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 362.11M | 376.51M | 230.24M | 245.90M | 267.43M |
|
|
|||||
| Total Current Assets | 362.11M | 376.51M | 230.24M | 245.90M | 267.43M |
| Net Property, Plant & Equipment | 1.47M | 1.67M | 587.00K | 816.00K | 1.03M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 350.00K | 56.00K | 55.00K | 55.00K | 56.00K |
| Total Assets | 363.93M | 378.23M | 230.88M | 246.77M | 268.52M |
|
|
|||||
| Total Accounts Payable | 2.15M | 1.79M | 1.87M | 1.70M | 2.52M |
| Total Accrued Expenses | 12.62M | 8.88M | 8.51M | 6.17M | 8.55M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 428.00K | 272.00K | 249.00K | 427.00K | 603.00K |
| Total Finance Division Other Current Liabilities | 455.00K | 477.00K | 320.00K | 532.00K | 278.00K |
| Total Other Current Liabilities | 455.00K | 477.00K | 320.00K | 532.00K | 278.00K |
| Total Current Liabilities | 15.65M | 11.41M | 10.96M | 8.83M | 11.94M |
|
|
|||||
| Total Current Liabilities | 15.65M | 11.41M | 10.96M | 8.83M | 11.94M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 919.00K | 1.03M | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.49M | 1.32M | 1.24M | 1.22M | 1.21M |
| Total Liabilities | 18.06M | 13.76M | 12.20M | 10.05M | 13.15M |
|
|
|||||
| Common Stock & APIC | 767.63M | 763.99M | 596.86M | 592.04M | 588.01M |
| Retained Earnings | -421.48M | -399.68M | -377.74M | -355.00M | -332.63M |
| Treasury Stock & Other | -279.00K | 160.00K | -443.00K | -321.00K | -19.00K |
| Total Common Equity | 345.87M | 364.47M | 218.68M | 236.72M | 255.37M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 345.87M | 364.47M | 218.68M | 236.72M | 255.37M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 345.87M | 364.47M | 218.68M | 236.72M | 255.37M |
|
|
|||||